456 / 492
ICCS S3-9
(P)
CONTENT VALIDITY OF NEW PNE QOL IMPACT QUESTIONNAIRE FOR
BEDWETTING CHILDREN.
Tove HOLM-LARSEN
1
, Marie SCHROEDER
2
, Ian HAMER
3
, Jonathan HOWELL
3
, Kristian JUUL
4
and Brenda CHEER
5
1) Pharma Evidence, 2200, DENMARK - 2) Aarhus University Hospital, Paediatric Research Laboratory Department of
Paediatrics, Aarhus, DENMARK - 3) SCIENSUS, West Sussex, UNITED KINGDOM - 4) FERRING PHARMACEUTICALS A/S,
GSAU, Copenhagen, DENMARK - 5) EDUCATION AND RESOURCES FOR IMPROVING CHILDHOOD CONTINENCE (ERIC,
Kingswood, UNITED KINGDOM
PURPOSE
There are few questionnaires assessing the impact of bedwetting in children and these are either too long or rather
negatively phrased. This study aimed to develop an electronic questionnaire directed at the child, positively phrased,
short and sensitive to treatment.
MATERIAL AND METHODS
A literature review of areas of relevance for bedwetting children was conducted. The content validity of the items was
explored through qualitative semi-structured interviews with Danish children, age 5-15, seeking treatment for
bedwetting and/or other bladder problems. A draft e-questionnaire was thereafter developed and tested for
completeness, understandability and adequate response options with bedwetting children in treatment in UK.
RESULTS
Nine one-to-one interviews were conducted with Danish children. The questions were considered relevant and
comprehensive, however one question ‘I sleep well’ was replaced with ’I enjoy sleepovers at my friends or at camp’ as
the majority of children considered this a major burden and a more relevant topic.
The e-questionnaire was tested in one UK focus group of 10 patients. The initial division in age groups was removed as
all patient groups could agree to the very simple questionnaire and design. The e-design was reported to be more easily
understandable after the facial expressions of the smiley faces were adjusted.
CONCLUSIONS
The PNE impact questionnaire has high content validity and will be tested in a real life study for reliability and sensitivity
in an online patient tool from April 2015.